• ESRD patients needing dialysis

• Urgent-start PD patients

• Patients with previous abdominal surgery

• Critical cases needing PD (pulmonary edema)

• Domestic & intl physicians/nurses in training

Taipei VGH introduced Taiwan's first peritoneal dialysis (PD) program in 1984, with over 40 years of experience and 2,000+ patient treatments, plus Taiwan's first cloud-connected automated PD (APD) management platform. Led by Prof. Szu-Yuan Li (Yang-Ming Chiao Tung University Medical School, PD Unit Director), the team pioneered a modified PD catheter insertion technique in 2021 (single-port laparoscopic-assisted Seldinger technique). Post-op waiting time is the world's shortest (dialysis next day) with lowest complications globally (surgical: 8.6% vs 21.8%; infection: 2.9% vs 11.9%). Over 250 modified insertions completed, enabling next-day dialysis without transitional hemodialysis; shorter hospitalization saves NHIA ~NT$300 million annually. Technique adopted by 14 domestic hospitals and 10 countries; JoVE intl crew recorded demo video for global medical education. The team leads in global PD-related SCI publications, with >2,300 citations in 5 years and 10 papers with >100 citations. Adopted by JAMA (IF 55) for ESRD-CHF medication recommendations. Awards: Wu Ta-Yu Award, Chen Wan-Yu Research Award, SNQ Gold/Silver, National Medical Quality EBM Gold, National Innovation, MOHW CKD Care 3-yr Distinguished.

• World-first modified PD catheter insertion (2021)

• Next-day PD start (urgent start PD)

• Cloud-connected APD platform (2019, Taiwan-first)

• Far-infrared (FIR) for peritoneal function

• Single-cell sequencing of PD pathophysiology

• Modified single-port blood clot removal

• >2,000 cumulative PD patients

• >250 modified insertions completed

• 14 trainees from 5 countries (past 5 yrs)

• 14 domestic hospitals adopted technique

• Doctors from 10 countries visited

• 28 community dialysis center partners

• Surgical complication 8.6% (vs 21.8% traditional)

• Infection 2.9% (vs 11.9% traditional)

• 1-day post-op wait (world-shortest)

• Best insertion success rate globally

• Saves medical expense 3000USD/patient

• Lowest PD peritonitis among medical centers

• Cloud APD 24/7 staff monitoring

• Color-flag alert recognition

• Proactive catheter slip/obstruction detection

• Monthly catheter review meeting

• Modified single-port blood clot removal

• IRB-approved patient outcome risk analysis

• Best long-term outcomes (media-praised)

• Mortality below national average

• Successful urgent-start PD critical cases

• National Smart Hospital Quality Mark

• Patient acceptance of modified insertion high

• PD SCI publications lead all global hospitals

• >2,300 citations in 5 years

• 10 papers with >100 citations

• JAMA (IF 55) cited team's clinical research

• Invited speaker ASN/KSN/APCN

• JoVE international platform surgery demo video

• SNQ Gold (2018), Silver (2022)

• National Medical Quality EBM Gold (2024)

• HPA Kidney Disease Promotion Distinguished (2023, 2024)

• MOHW CKD 3-yr Distinguished/Model/Gold (2025)

• National Innovation Award (2023/2024/2025)